PCV49 COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK
May 1, 2019, 00:00
10.1016/j.jval.2019.04.485
https://www.valueinhealthjournal.com/article/S1098-3015(19)30677-1/fulltext
Title :
PCV49 COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30677-1&doi=10.1016/j.jval.2019.04.485
First page :
Section Title :
Open access? :
No
Section Order :
10127